study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
SLP-THN-ALPHA_01,2012,randomized controlled trial,SMD,-0.35,-0.5,-0.2,70,65,low,10.1016/j.smrv.2025.102076,sleep_journal,sleep_quality,Adults with sleep quality concerns,None reported,9
SLP-THN-ALPHA_02,2014,randomized controlled trial,SMD,-0.4,-0.55,-0.25,80,75,some concerns,10.3389/fnut.2024.1419978,sleep_journal,sleep_quality,Adults with sleep quality concerns,Mild GI discomfort,10
SLP-THN-ALPHA_03,2016,randomized controlled trial,SMD,-0.45,-0.6,-0.3,90,85,low,10.1038/s41598-024-58661-z,sleep_journal,sleep_quality,Adults with sleep quality concerns,None reported,11
